274 related articles for article (PubMed ID: 32778697)
1. Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel.
Wang F; Su H; Xu D; Dai W; Zhang W; Wang Z; Anderson CF; Zheng M; Oh R; Wan F; Cui H
Nat Biomed Eng; 2020 Nov; 4(11):1090-1101. PubMed ID: 32778697
[TBL] [Abstract][Full Text] [Related]
2. Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
Muñoz NM; Williams M; Dixon K; Dupuis C; McWatters A; Avritscher R; Manrique SZ; McHugh K; Murthy R; Tam A; Naing A; Patel SP; Leach D; Hartgerink JD; Young S; Prakash P; Hwu P; Sheth RA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589526
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy.
Zhou Q; Shao S; Wang J; Xu C; Xiang J; Piao Y; Zhou Z; Yu Q; Tang J; Liu X; Gan Z; Mo R; Gu Z; Shen Y
Nat Nanotechnol; 2019 Aug; 14(8):799-809. PubMed ID: 31263194
[TBL] [Abstract][Full Text] [Related]
4. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
[TBL] [Abstract][Full Text] [Related]
5. Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways.
Wang Y; Li S; Hu M; Yang Y; McCabe E; Zhang L; Withrow AM; Ting JP; Liu R
Nat Nanotechnol; 2024 Jun; 19(6):856-866. PubMed ID: 38480836
[TBL] [Abstract][Full Text] [Related]
6. Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour.
Jeong SH; Yang MJ; Choi S; Kim J; Koh GY
Nat Commun; 2021 Jul; 12(1):4405. PubMed ID: 34285232
[TBL] [Abstract][Full Text] [Related]
7. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
[TBL] [Abstract][Full Text] [Related]
8. Intratumoural immunotherapies in oncology.
Xu W; Atkinson VG; Menzies AM
Eur J Cancer; 2020 Mar; 127():1-11. PubMed ID: 31962197
[TBL] [Abstract][Full Text] [Related]
9. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
10. A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids.
Li X; Kong X; Zhang J; Wang Y; Wang Y; Shi S; Guo G; Luo F; Zhao X; Wei Y; Qian Z
J Pharm Sci; 2011 Jan; 100(1):232-41. PubMed ID: 20533555
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of 10-hydroxy camptothecin in supramolecular hydrogel as an injectable drug delivery system.
Li R; Shu C; Wang W; Wang X; Li H; Xu D; Zhong W
J Pharm Sci; 2015 Jul; 104(7):2266-75. PubMed ID: 25980666
[TBL] [Abstract][Full Text] [Related]
13. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
[TBL] [Abstract][Full Text] [Related]
14. Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy.
Xu L; Deng H; Wu L; Wang D; Shi L; Qian Q; Huang X; Zhu L; Gao X; Yang J; Su Y; Feng J; Zhu X
ACS Nano; 2023 Jun; 17(11):10090-10103. PubMed ID: 37253192
[TBL] [Abstract][Full Text] [Related]
15. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
[TBL] [Abstract][Full Text] [Related]
16. Covalently crosslinked organophosphorous derivatives-chitosan hydrogel as a drug delivery system for oral administration of camptothecin.
Martínez-Martínez M; Rodríguez-Berna G; Bermejo M; Gonzalez-Alvarez I; Gonzalez-Alvarez M; Merino V
Eur J Pharm Biopharm; 2019 Mar; 136():174-183. PubMed ID: 30654016
[TBL] [Abstract][Full Text] [Related]
17. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models.
Jing W; McAllister D; Vonderhaar EP; Palen K; Riese MJ; Gershan J; Johnson BD; Dwinell MB
J Immunother Cancer; 2019 Apr; 7(1):115. PubMed ID: 31036082
[TBL] [Abstract][Full Text] [Related]
18. Intratumoural administration and tumour tissue targeting of cancer immunotherapies.
Melero I; Castanon E; Alvarez M; Champiat S; Marabelle A
Nat Rev Clin Oncol; 2021 Sep; 18(9):558-576. PubMed ID: 34006998
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling.
Shi Y; Zheng W; Yang K; Harris KG; Ni K; Xue L; Lin W; Chang EB; Weichselbaum RR; Fu YX
J Exp Med; 2020 May; 217(5):. PubMed ID: 32142585
[TBL] [Abstract][Full Text] [Related]
20. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.
Corrales L; Glickman LH; McWhirter SM; Kanne DB; Sivick KE; Katibah GE; Woo SR; Lemmens E; Banda T; Leong JJ; Metchette K; Dubensky TW; Gajewski TF
Cell Rep; 2015 May; 11(7):1018-30. PubMed ID: 25959818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
